Does NIVOLUMAB Cause Hepatic failure? 382 Reports in FDA Database

Q: Does NIVOLUMAB cause Hepatic failure?

382 reports of Hepatic failure have been filed with the FDA for NIVOLUMAB, representing 0.4% of all NIVOLUMAB adverse event reports.

Q: How dangerous is Hepatic failure from NIVOLUMAB?

Of 382 reports, 252 (66.0%) resulted in death and 229 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 382 reports of Hepatic failure have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.4% of all adverse event reports for NIVOLUMAB.

382

Reports of Hepatic failure with NIVOLUMAB

0.4%

of all NIVOLUMAB reports

252

Deaths

229

Hospitalizations

How Dangerous Is Hepatic failure From NIVOLUMAB?

Of the 382 reports, 252 (66.0%) resulted in death, 229 (59.9%) required hospitalization, and 65 (17.0%) were considered life-threatening.

Is Hepatic failure Listed in the Official Label?

Yes, Hepatic failure is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.

What Other Side Effects Does NIVOLUMAB Cause?

Death (11,216) Malignant neoplasm progression (9,363) Off label use (5,208) Diarrhoea (4,692) Fatigue (3,709) Pyrexia (3,454) Intentional product use issue (3,297) Rash (2,816) Nausea (2,805) Decreased appetite (2,619)

What Other Drugs Cause Hepatic failure?

ACETAMINOPHEN (1,392) RIBAVIRIN (888) CYCLOPHOSPHAMIDE (629) METHOTREXATE (598) BEVACIZUMAB (558) SOFOSBUVIR (525) RITUXIMAB (513) VINCRISTINE (468) DOXORUBICIN (462) PREDNISOLONE (425)

Which NIVOLUMAB Alternatives Have Lower Hepatic failure Risk?

NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW NIVOLUMAB vs NIZATIDINE NIVOLUMAB vs NOMEGESTROL NIVOLUMAB vs NORDAZEPAM NIVOLUMAB vs NOREPINEPHRINE

NIVOLUMAB Full Profile All Hepatic failure Reports All Drugs Causing Hepatic failure NIVOLUMAB Demographics